Hypertension Longitudinal Data Platform in Tianjin

NCT ID: NCT06415071

Last Updated: 2024-05-17

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 1172280 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2015-01-01
• Study Completion Date: 2021-12-31

Brief Summary

Hypertension is one of the leading causes of death globally, and ranks among the top four risk factors for mortality and DALYs in China. However, large-scale population based longitudinal research data source for hypertension is lacking in China. Thus, we aimed to establish the first and most extensive hypertension database in China using healthcare data from the Tianjin city. This hypertension longitudinal data platformlinked electronic medical records (EMR) system 35 stores healthcare data of 1.17 million hypertension patients, from 43 tertiary hospitals and 39 secondary hospitals, along with a public health follow-up management system. Data on demographics, diagnosis, drug prescription, laboratory test, physical examination, and cost information were collected, the median follow-up time was 4.3 [ interquartile range (IQR): 2.7-5.8] years, and the median number of outpatient visits was 32 (IQR: 15-64) per patient. This database can address research needs including, drug utilization pattern analysis, policy implementation evaluation, digital medical device development, and other real world evidence studies. These researches would provide robust evidence to assist improving patient health outcomes and healthcare system decision-making.

Conditions

Hypertension

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Study Groups

Patients diagnosed with hypertension

No intervention

Intervention Type: OTHER

Exposures of interest would be clearly defined according to a specific research question and identified from the database

Interventions

No intervention

Exposures of interest would be clearly defined according to a specific research question and identified from the database

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Hypertension first diagnosed between January 1, 2015 and December 31, 2021
• Aged 18 years or older

Exclusion Criteria

• None

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tianjin Health Care Big Data Ltd.

UNKNOWN

Sponsor Role: collaborator

Tianjin Health Commission

UNKNOWN

Sponsor Role: collaborator

West China Hospital

OTHER

Sponsor Role: lead

Responsible Party

Sun Xin

Professor and director of Chinese Evidence-based Medicine Center

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Xin Sun, Phd

Role: STUDY_DIRECTOR

West China Second University Hospital

Locations

The West China Hospital of Sichuan university

Chengdu, Sichuan, China

Countries

China

Other Identifiers

HYLERP

Identifier Type: -

Identifier Source: org_study_id